SCHEMBL31039261

SCHEMBL31039261

Cc1cc(Br)cc2c1cnn2C(C)N(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EZH2 Q15910 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7256657 0.75 KMO (0.40)
SCHEMBL25411517 0.73 IDO1 (0.43)
SCHEMBL29426945 0.73 IDO1 (0.43)
SCHEMBL30002750 0.72 HDAC8 (0.44)
SCHEMBL31039286 0.70 EGFR (0.41)
SCHEMBL16616905 0.69 ADORA2A (0.44)
SCHEMBL29035700 0.69 CYP1A2 (0.35)
SCHEMBL19531886 0.68 KDM5A (0.39) EZH2
SCHEMBL31039265 0.67 KMO (0.35)
SCHEMBL23994142 0.65 CYP17A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655296-A1 CBL-B INHIBITORS Aurigene Oncology Limited (IN) 2025-12-03 EP disclosed
WO-2024156938-A1 CBL-B INHIBITORS ORION CORPORATION (FI) 2024-08-02 WO disclosed